CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Stifel Nicolaus 2011 Healthcare Conference on Thursday, September 8, 2011 at 10:55 a.m. ET at the Four Seasons in Boston.
